Literature DB >> 14514377

[Significance of a novel fetal RNA-binding protein p62 expression in hepatocellular carcinoma].

Hong-liu Qian1, Shou-hui Chen, Xuan-xian Peng.   

Abstract

OBJECTIVE: To investigate the histological characteristics of hepatocellular carcinoma with p62 expression, and the correlation of p62 protein with biological characteristics of the cancer cells such as proliferation and metastasis.
METHODS: The immunohistochemical expression of p62 and Ki-67 were studied in 40 primary hepatocellular carcinomas.
RESULTS: 67.5% (27/40) exhibited positive staining of p62 protein in the cytoplasm of malignant cells, of which the strong positivity was mainly found in pathologic grade III cases. The cases with strong positive staining of p62 exhibited extensive fibrosis in the stroma and massive necrosis of the tumor. These cases also exhibited high proliferation activity, the mean Ki-67 labeling index was 28.3% +/- 15.1%, which was significantly higher than that in p62 negative ones (t = 3.087, P = 0.005). Three of five cases with lung or celiac lymph node metastasis exhibited strong positive staining of p62.
CONCLUSION: There is some relationship between the expression of p62 protein, proliferation activity and metastasis of cancer cells as well as with the microenvironment which have abundant fibrous tissue in the stroma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514377

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  3 in total

1.  RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABAA Receptor-γ2.

Authors:  Yi-An Zhang; Hai-Ning Liu; Ji-Min Zhu; Dan-Ying Zhang; Xi-Zhong Shen; Tao-Tao Liu
Journal:  J Biomed Sci       Date:  2016-10-12       Impact factor: 8.410

2.  Association of p62/SQSTM1 excess and oral carcinogenesis.

Authors:  Takuma Inui; Tokuhiro Chano; Mikiko Takikita-Suzuki; Masanori Nishikawa; Gaku Yamamoto; Hidetoshi Okabe
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

Review 3.  P62: An emerging oncotarget for osteolytic metastasis.

Authors:  Jing Zhang; Zuozhang Yang; Jian Dong
Journal:  J Bone Oncol       Date:  2016-02-03       Impact factor: 4.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.